OptiBiotix Health PLC
Other OTCTotal Valuation
OptiBiotix Health PLC carries a market capitalization of 11.36M, placing it among publicly traded companies globally. Its enterprise value stands at -731,171.62, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.36M |
| Enterprise Value | -731,171.62 |
Share Statistics
OptiBiotix Health PLC currently has 97.94M shares outstanding.
| Shares Outstanding | 97.94M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
OptiBiotix Health PLC trades at a trailing price-to-earnings ratio of 5.02. The price-to-sales ratio is 12.86, and the price-to-book ratio stands at 0.00.
| PE Ratio | 5.02 |
| PS Ratio | 12.86 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | 65.27 |
| P/OCF Ratio | 65.27 |
Financial Position
OptiBiotix Health PLC maintains a current ratio of 3.87, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.87 |
| Quick Ratio | 2.01 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
OptiBiotix Health PLC posts a return on equity of 40.41 and a return on invested capital of -1.88.
| Return on Equity (ROE) | 40.41 |
| Return on Assets (ROA) | 37.31 |
| Return on Invested Capital (ROIC) | -1.88 |
| Return on Capital Employed (ROCE) | 40.41 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.96 |
Stock Price Statistics
OptiBiotix Health PLC's stock has declined approximately -50% over the past 52 weeks. The 50-day moving average sits at 0.11, while the 200-day moving average is 0.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -50% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.11 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, OptiBiotix Health PLC generated 1.24M in revenue and converted that into 3.19M in net income, yielding earnings per share of 0.00. EBITDA reached -147,805.00, while operating income came in at -147,805.00.
| Revenue | 1.24M |
| Gross Profit | 33,155.00 |
| Operating Income | -147,805.00 |
| Pretax Income | 3.19M |
| Net Income | 3.19M |
| EBITDA | -147,805.00 |
| EBIT | -147,805.00 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
Total book value stands at 8.40M, with working capital of 1.06M providing operational flexibility.
| Cash & Cash Equivalents | 739,000.00 |
| Total Debt | N/A |
| Net Debt | -739,000.00 |
| Equity (Book Value) | 8.40M |
| Book Value Per Share | 0.09 |
| Working Capital | 1.06M |
Cash Flow
OptiBiotix Health PLC produced 244,897.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | 244,897.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | 244,897.00 |
| FCF Per Share | 0.00 |
Margins
OptiBiotix Health PLC operates with a gross margin of 2.67, reflecting its pricing power and cost economics. The operating margin of -11.89 and net profit margin of 256.23 provide insight into operational efficiency.
| Gross Margin | 2.67 |
| Operating Margin | -11.89 |
| Pretax Margin | 256.23 |
| Profit Margin | 256.23 |
| EBITDA Margin | -11.89 |
Dividends & Yields
The company's payout ratio of 53.70 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.00 |
| Dividend Yield | N/A |
| Payout Ratio | 53.70 |
| Shareholder Yield | 21,848.36 |
| FCF Yield | 1.53 |
Scores
OptiBiotix Health PLC posts an Altman Z-Score of 0.37, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.37 |